Controls (n = 77) | FES participants (n = 77) | Note | |
---|---|---|---|
Sex – female N (%) | 34 (44%) | 34 (44%) | NS |
Age, mean (S.D.) | 28.32 (7.02) | 28.51 (7.03) | t = 0.16; p = 0.87 |
Diagnosis (Schizophrenia/Acute polymorphic psychotic disorder) (%) | n/a | 46 (59.7%) / 31 (40.3%) | n/a |
Median duration of illness, months (SD) | n/a | 3 (7.1)a | n/a |
Drug dose upon MRI – median chlorpromazine equivalent (SD) | n/a | 337 (234.8)a | n/a |
PANSS positive mean (SD) | n/a | 13.9 (4.9) | n/a |
PANSS negative mean (SD) | n/a | 15.7 (6.1) | n/a |
PANSS general mean (SD) | n/a | 32.8 (8.5) | n/a |
PANSS total mean (SD) | n/a | 62.4 (16.7) | n/a |